Management of immune-checkpoint inhibitor (ICI)-related thyroid dysfunction: An avenue for quality improvement.

Authors

null

Subhash Edupuganti

UPMC Hillman Cancer Center, Pittsburgh, PA

Subhash Edupuganti , Diwakar Davar

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Palliative and Supportive Care

Sub Track

Quality Improvement Research and Implementation Science

Citation

JCO Oncol Pract 20, 2024 (suppl 10; abstr 309)

DOI

10.1200/OP.2024.20.10_suppl.309

Abstract #

309

Poster Bd #

F23

Abstract Disclosures

Similar Posters

First Author: Shiro Kimbara

First Author: Caroline Robert

First Author: Astrid van Barneveld

First Author: Guillermo De Velasco